- Home
- TMUS vs NVO Comparison
TMUS vs NVO Comparison
Compare TMUS & NVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TMUS
- NVO
- Stock Information
- Founded
- TMUS 1994
- NVO 1923
- Country
- TMUS United States
- NVO Denmark
- Employees
- TMUS N/A
- NVO N/A
- Industry
- TMUS Telecommunications Equipment
- NVO Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- TMUS Telecommunications
- NVO Health Care
- Exchange
- TMUS Nasdaq
- NVO Nasdaq
- Market Cap
- TMUS 264.8B
- NVO 278.0B
- IPO Year
- TMUS N/A
- NVO N/A
- Fundamental
- Price
- TMUS $242.72
- NVO $54.29
- Analyst Decision
- TMUS Buy
- NVO Buy
- Analyst Count
- TMUS 23
- NVO 7
- Target Price
- TMUS $257.98
- NVO $98.00
- AVG Volume (30 Days)
- TMUS 3.9M
- NVO 14.9M
- Earning Date
- TMUS 10-23-2025
- NVO 11-05-2025
- Dividend Yield
- TMUS 1.45%
- NVO 2.27%
- EPS Growth
- TMUS 32.79
- NVO 24.25
- EPS
- TMUS 10.59
- NVO 3.93
- Revenue
- TMUS $84,052,000,000.00
- NVO $49,108,936,497.00
- Revenue This Year
- TMUS $8.80
- NVO $10.01
- Revenue Next Year
- TMUS $5.42
- NVO $9.93
- P/E Ratio
- TMUS $22.92
- NVO $13.81
- Revenue Growth
- TMUS 6.27
- NVO 20.91
- 52 Week Low
- TMUS $193.27
- NVO $45.05
- 52 Week High
- TMUS $276.49
- NVO $138.22
- Technical
- Relative Strength Index (RSI)
- TMUS 40.93
- NVO 43.87
- Support Level
- TMUS $237.40
- NVO $54.60
- Resistance Level
- TMUS $256.69
- NVO $57.35
- Average True Range (ATR)
- TMUS 4.57
- NVO 1.15
- MACD
- TMUS -1.72
- NVO 0.34
- Stochastic Oscillator
- TMUS 22.02
- NVO 27.94
About TMUS T-Mobile US Inc.
Deutsche Telekom merged its T-Mobile USA unit with prepaid specialist MetroPCS in 2013, and that firm merged with Sprint in 2020, creating the second-largest wireless carrier in the US. T-Mobile now serves 80 million postpaid and 25 million prepaid phone customers, equal to around 30% of the US retail wireless market. The firm entered the fixed-wireless broadband market aggressively in 2021 and now serves 7 million residential and business customers. In addition, T-Mobile provides wholesale services to resellers.
About NVO Novo Nordisk A/S
With roughly one third of the global branded diabetes treatment market, Novo Nordisk is the leading provider of diabetes-care products in the world. Based in Denmark, the company manufactures and markets a variety of human and modern insulins, injectable diabetes treatments such as GLP-1 therapy, oral antidiabetic agents, and obesity treatments. Novo also has a biopharmaceutical segment (constituting less than 10% of revenue) that specializes in protein therapies for hemophilia and other disorders.